Efficacy and Safety of Mirogabalin Therapy for Paclitaxel-Induced Peripheral Neuropathy (MICHEL Study): A Pilot Study.
Oncology • Vol. 103, Issue 11 • 2025
Mirogabalin as a novel calcium channel αδ ligand for the treatment of neuropathic pain: a review of clinical update.
Frontiers in pharmacology • Vol. 15 • 2024
Mirogabalin, a novel αδ ligand, is not a substrate of LAT1, but of PEPT1, PEPT2, OAT1, OAT3, OCT2, MATE1 and MATE2-K.
Xenobiotica; the fate of foreign compounds in biological systems • Vol. 52, Issue 9-11 • 2022
Mirogabalin in Japanese Patients with Renal Impairment and Pain Associated with Diabetic Peripheral Neuropathy or Post-Herpetic Neuralgia: A Phase III, Open-Label, 14-Week Study.
Journal of pain research • Vol. 13 • 2020